On Cancer - April 23, 2015Should I Consider Multigene Panel Testing?
Doctors and researchers have established that the genes we are born with may increase our risk of developing certain types of cancer. For some people, becoming aware that they carry a cancer-causing genetic mutation may spur them to take preventive action. Women with BRCA1 and BRCA2 mutations may pursue surgery to help prevent breast cancer, for example.Read more
On Cancer - February 26, 2015
Surgery is the most common treatment for people with rectal cancer, but an operation is just the first step when it comes to restoring quality of life. It’s common for people who’ve had sphincter-preserving or colostomy surgery (the two major types of surgeries for rectal cancer) to experience lingering side effects related to bowel, bladder, or sexual function, some of which can be permanent. Read more
Meet Thoracic Surgeon David Jones
David Jones is a surgeon who cares for patients with cancers of the chest, including lung and esophageal cancers. As Chief of the Thoracic Surgery Service, he shares his thoughts on the future of treatment for these diseases and offers insight into the strengths of the Memorial Sloan Kettering surgical team. In addition to seeing patients in Manhattan, Dr. Jones will soon be practicing at MSK's new ambulatory cancer care facility opening in West Harrison, NY in October 2014.
On Cancer - July 14, 2014Meet Medical Oncologist William Tap
William Tap is Chief of Memorial Sloan Kettering’s Sarcoma Medical Oncology Service. Learn more about how he chose a career in providing cutting-edge treatment to people with different types of soft tissue sarcoma and why patients benefit from coming to Memorial Sloan Kettering for treatment.Read more
On Cancer - July 17, 2014Hsp90: A Very Promising Target for Cancer Therapy
Drug discovery is “a long, complex effort,” says chemical biologist Gabriela Chiosis, a member of the Sloan Kettering Institute’s Molecular Pharmacology and Chemistry Program. She should know. The journey to the discovery in her laboratory of how a small molecule can be used to block the activity of a cancer-promoting protein began more than a decade ago.Read more